MET and head and neck squamous cell carcinoma: The present state of knowledge about c-MET signaling and its effects on HNSCC requires a better understanding of how to overcome the overall survival rate of the patients because c-MET signaling is intertwined with other signaling pathways, and more robust and specialized therapeutics are possible, leading to better clinical outcomes.